News | PET-CT | November 03, 2015

VG60 enhancements will facilitate streamlining of imaging, radiation oncology to enhance cancer diagnosis and treatment

University of Tennessee, UT Medical Center, PET/CT software, radiation oncology, Siemens

Image courtesy of Siemens Healthcare


November 3, 2015 — The University of Tennessee Medical Center announced it has implemented new software aimed at significantly improving positron emission tomography/computed tomography (PET/CT) image quality and radiation oncology services. It is first time in the world this software is being utilized.

Assistant Professor and Director of UT Medical Center’s Molecular Imaging and Translational Research Program, Dustin Osborne, M.D., explains patients can now benefit from the newly released VG60 software update to the Siemens Biograph 64 mCT Flow PET/CT units utilized inside the medical center.

“UT Medical Center was chosen to pioneer this PET/CT software because of our unique workflows that blend standard oncological imaging with radiation therapy,” said Osborne. “This software contains a number of new features that result in improved radiation therapy services. Plus, combining standard PET/CT and radiation oncology workflows provides more convenience for patients as they can have multiple procedures performed during one appointment.”

According to Osborne, VG60 utilizes features that improve the image quality of PET/CT scans, which have previously been distorted by software limitations and common human error.

“A PET/CT scan is sensitive to any movement or abnormality in the human body which can blur the images,” said Osborne. “The simple respiratory motion of a patient during a scan can have a negative impact on accurate cancer diagnosis and therapy monitoring.”

Osborne explains that this software is significant in the benefits it provides as it has the ability to remove metal artifacts such as implants or dental work from the diagnostic CT images. Patients, physicians and clinicians viewing the scans will collectively benefit from improved large field of view imaging as well as respiratory motion correction that can be added seamlessly to any standard whole-body image study.

“This software solves a number of challenges for using PET/CT in radiation oncology while also vastly improving diagnostic image quality,” said Osborne. “Most importantly, it helps in the expedited diagnosis of our patients. The fact that UT Medical Center is the first in the world to utilize the software is a testament to our physicians and the thousands of patients that annually employ our radiological services.”

For more information: www.utmedicalcenter.org


Related Content

News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
Subscribe Now